MyFinsight
Home
Blog
About
Back
Income Statement
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)
source: myfinsight.com
Comprehensive loss
-$24.853M
Interest income
$9.718M
Net loss
-$21.972M
Unrealized loss on
available-for-sale securities, net
-$2.881M
Total other income
$9.718M
Loss from operations
-$31.69M
Collaboration revenue
$10.267M
Total operating
expenses
$41.957M
Research and development
$30.994M
General and
administrative
$10.963M
Back